BSE filing, NSE: WSFIN. Summary written from the filing by ALFA Finder's alert engine.
WSFx Global Pay Ltd: key numbers
- Share price
- ₹67.03
- Market cap
- ₹82.25 Cr
- Revenue (annual)
- ₹107.9 Cr
- Net profit (annual)
- ₹6.14 Cr
- P/E (TTM)
- 12.0×Sector 19.7×
- Promoter holding
- 56.94%-0.06% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from WSFx Global Pay Ltd
All →WSFx Global Pay Earnings Call Transcript: Key Takeaways
WSFx delivered record Q2 turnover growth led by student remittances, despite macro headwinds in the US market. The pivot toward high-volume B2B channels is driving scale but compressing margins due to higher commission payouts.
WSFx Global Pay Investor Presentation: Key Takeaways
Q2 FY27 revenue from operations ₹44.58 Cr (+30.0% YoY), PBT ₹5.33 Cr (+9.6%), gross turnover ₹2,914 Cr (+41.2%). Perpetual AD-II licence received 30 July 2026.
WSFx Global Pay Employee Stock Options
WSFx Global Pay allotted 1,62,500 ESOPs to eligible employees under its 2018 scheme, effective 27 October 2026. Options vest in tranches through October 2029.
WSFx Global Pay Capacity Expansion
WSFx Global Pay's board approved opening a new branch office in Kanpur, Uttar Pradesh, expected on or before December 15, 2026. The branch is part of the company's regional business expansion.
- new branches
- 1.0 branches
WSFx Global Pay Q2 FY27 Results: Net Profit ₹4.3 Cr, Up 16.2% YoY
WSFx Global Pay Ltd reported revenue from operations of ₹44.6 Cr (+30.0% YoY) and net profit of ₹4.3 Cr (+16.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹4.3 Cr · +16.2% YoY
WSFx Global Pay Board Meeting Date
WSFx Global Pay Limited scheduled a Board meeting for October 26, 2026, to consider and approve the unaudited financial results for the quarter ended September 30, 2026.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date